Trial Design
OCD
SECONDARY, RECRUITMENT
The study was a 6-week, assessor-blinded, clinical RCT with patients with OCD allocated 1:1:1 to the ICBT, CBGT, and TAU groups. Primary and secondary outcomes were measured 3 times: at baseline (0 weeks), during treatment (3 weeks), and after treatment (6 weeks). The study was carried out at the Shanghai Mental Health Center in Shanghai, China, and was registered in the Clinical Trial Registry (registration no. ChiCTR1900023840). Recruitment and intervention for the trial started in 2018.